For citation purposes: Wang H, Liu Y, Han C. The analgesic effect of several edible mushrooms. OA Alternative Medicine 2013 Oct 01;1(3):22.

Review

 
Remedies

The analgesic effect of several edible mushrooms

H Wang, Y Liu, C Han*
 

Authors affiliations

School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355 P. R. China

* Corresponding author Email: shandongtcmh@163.com

† These authors contributed equally to this study.

Abstract

Introduction

Edible mushrooms, a valuable source of bioactive compounds and nutrients, have been consumed as part of the diet in some countries for thousands of years. They are quite high in protein, carbohydrate and fibre and low in fat content with low trans-isomers of unsaturated fatty acids. In addition, they also have many components such as triterpenes, phenolic compounds, chitosan, eritadenine, sterols (such as ergosterol), triterpenes, etc., which are considered momentous agents for some hitherto unknown healthy properties. Recently, edible mushrooms have become increasingly attractive as functional foods and medicines to treat diseases including cancer, diabetes, inflammation and ache due to the presence of these active components. Pain is an unpleasant sensation, which is a typical response to an untoward event associated with tissue damage, such as injury and inflammation. The aims of this review are to report the positive analgesic effect of several edible mushrooms on pain and its relevant active constituents.

Conclusion

In our review, the edible mushrooms including Pleurotus pulmonarius, Agaricus brasiliensis, Agaricus bisporus var. hortensis, Agaricus macrosporus, Coriolus versicolor and Cordyceps sinensis have been investigated that possess antinociceptive and anti-inflammatory effects owing to their bioactive components such as β-glucan, agaricoglyceride A, polysaccharopeptide and cordymin as well as other active components. What is more, there are barely any side effects caused by the toxicity of edible mushrooms in vitro and in vivo. However, further research is required with clinical trials and applications.

Introduction

Pain is a physiologically relevant sensation necessary to detect and/or prevent injury; it is sometimes useful to us[1,2]. Typically, it is a direct response to an untoward event associated with tissue damage, such as injury and inflammation, but severe pain can arise independently of any obvious redisposing cause, or precipitate healing after injury for a relatively long time. It can also occur as a consequence of brain or nerve injury. Pain signalling to the central nervous system is initiated when harmful excitement and primary afferent nociceptive C and A fibres are frequently caused by activation of several types of ionotropic channels and etabotropic receptors[3,4]. In fact, transient receptor potential and acid-sensing ion channels participate in generating nociceptive signals in response to various specific noxious stimuli[4,5,6]. Activity of some of these channels and other proteins implicated in nociceptive signalling pathways can be upregulated by protein kinase C[7,8,9]. Thus, pain is generated.

Edible mushrooms are the fleshy and edible fruiting bodies of several species of fungi, typically produced above ground on soil or on its food source[10]. They have been used as delicious foods and as healthy nutritional supplements for several centuries. For the Chinese, some mushrooms are especially regarded as medical substances that boost health and increase longevity, which is attributed to their far-ranging functions, for example antinociceptive, anti-inflammatory, immunity, anti-tumour, ascorbic and so on. Mushrooms are quite high in protein (19–35%) and low in fat. Miles et al. concluded that mushrooms also contain relatively large amounts of carbohydrate and fibre, ranging from 51% to 88% and from 4% to 20%, respectively (dry weight). In addition, mushrooms contain significant amounts of vitamins, namely thiamin, ascorbic acid, riboflavin and vitamin D2, as well as minerals[11,12]. In addition to their nutritional value, some mushrooms may also have a medicinal value: anti-tumour, antiviral and hypolipidemic effects have been reported[11,12,13]. They form a huge, but largely untapped powerful source of new pharmaceutical products[14,15]. They are low-calorie foods with very little fat and are highly suitable for obese persons[16]. Their consumption is widespread in China, Japan, Korea, Taiwan, Italy and Spain, among other countries[17,18,19].

In this review, we intend to discuss the result of research on the antinociception effect of edible mushrooms over the past two decades, emphasising animal studies as well as supporting mechanistic studies. We selected several typical edible fungi which result in pain relief. Our goals are to evaluate the analgesic effect of edible fungus, identify some putative bioactive compounds involved in the effect and stimulate further work in the field.

Discussion

The authors have referenced some of their own studies in this review. The protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed. Animal care was in accordance with the institution guidelines.

Analgesic effect of several edible mushrooms

Oyster mushrooms

Pleurotus is a genus of gilled mushrooms, one of the most widely eaten mushrooms. Species of Pleurotus are commonly known as oyster mushrooms and are some of the most commonly cultivated edible mushrooms in the world. The genus Pleurotus include edible and medicinal species, most of them being currently commercialised in China[20]. The fungi are rich in proteins, vitamins, carbohydrates, minerals and dietary fibres. Basidiomycetes have been widely studied over the past 30 years in the light of their polysaccharide composition and therapeutic application[21,22].

Pleurotus pulmonarius

Pleurotus pulmonarius, also known as oyster mushroom, is a common edible mushroom consumed worldwide due to its several polysaccharides, besides high amount of proteins, essential amino acids and vitamins[23,24]. A variety of biological effects have been ascribed to β-glucans, such as anti-inflammatory, antioxidant, anti-tumoural, immunomodulatory and antinociceptive properties[25,26,27,28]. There have been some literature research showing that pulmonarius have analgesic effects[29,30,31,32]. Smiderle et al.[29] isolated β-glucan (GL) with hot water from the basidiomycete P. pulmonarius and found the glucan had potent anti-inflammatory and antinociceptive activities in mice. Animals treated with β-glucan showed a reduction of 85 ± 5% of writhes induced by acetic acid and the significant inhibition of both the early (neurogenic pain) and the late (inflammatory pain) phases of formalin-induced licking in 43 ± 5% and 96 ± 4%, respectively. Then, the results showed that P. pulmonarius had notable analgesic and anti-inflammatory effects due to the inhibition of pro-inflammatory cytokines[29]. The structure of β-D-glucan was characterised using mono- and two-dimensional NMR spectroscopy, methylation analysis and a controlled Smith degradation[20,29]. And the dates showed that it had a main chain of (1 → 6)-linked α-D-galactopyranosyl and 3-O-methyl-α-D-galactopyranosyl units, both of which are partially substituted at O-2 by β-D-mannopyranosyl nonreducing ends (Figure 1).

Chemical structure of β-glucan isolated from Pleurotus pulmonarius.

In order to evaluate the involvement of transient receptor potential (TRP) channels and protein kinase C (PKC) on antinociceptive effect of a (1 → 3), (1 → 6)-linked β-D-glucan (GL), Baggio et al.[30] isolated GL from P. pulmonarius to treat it with intraperitoneal administration in mice. In this study, nociceptive responses, induced by intraplantar injections of capsaicin, cinnamaldehyde, menthol, acidified saline and phorbol myristate acetate (PMA), were significantly inhibited by GL. The results demonstrated that GL displayed pronounced systemic antinociceptive properties in chemical models of nociception in mice as a result of the inhibition of PKCε[30]. In addition, GL isolated from P. pulmonarius could dramatically inhibit acute and neuropathic pain in mice through mechanisms that involve the inhibition of ionotropic glutamate receptors and the interleukin-1β pathway[31].

Pleurotus florida

Pleurotus florida, an American oyster mushroom, has been reported to possess antioxidant, immunostimulator, anti-tumour and anti-inflammatory activities[32,33]. The analgesic and anti-inflammatory activity of P. florida was evaluated using a hot plate method, tail flick method, acetic acid-induced writhing, formalin-induced pain and carrageenan-induced inflammation in rats[34]. Animals treated orally with hydroethanolic extract (HEE) of P. florida in a dose-dependent manner were tested for nociceptive response with these methods. Then, results demonstrated P. florida exerted excellent analgesic and anti-inflammatory activity in rats on account of myoconstituents like flavonoids, phenolics, polysaccharides and polysaccharopeptides[34]. Simultaneously, the antinociceptive activity of HEE of P. florida is related to the activation of the opioid system.

Pleurotus eous and Pleurotus ostreatus

Pleurotus mushrooms are the second most important mushrooms in terms of production in the world. Furthermore, this species has been of interest to researchers because its phytochemical constituents are similar to those of P. pulmonarius, P. florida, Pleurotus eous and Pleurotus ostreatus, which are popularly used in medicines. The ethyl acetate, methanol and aqueous extracts of P. eous mushroom were investigated to evaluate the analgesic activity using acetic acid-induced writhing, hot-plate, tail immersion and tail-clip tests[35]. The dates showed that these extracts of P. eous produced significant reduction in the number of writhes and markedly raised the pain threshold at different times of observation in comparison with the control (p < 0.05). The extracts also caused a notable inhibition of pain in the tail-clip test. Thus, the results of this study revealed that extracts of P. eous possessed potent analgesic property and could serve as a base for future drugs[35].

Similarly, the antinociceptive potential of P. ostreatus was also investigated in rats through the hot-plate, tail-flick and formalin tests[36]. The reaction times on hot-plate and tail-flick tests were significantly prolonged and pain was significantly suppressed in both phases in the formalin test. The research results showed that P. ostreatus had antinociception against neurogenic and continuous inflammatory pain possibly by opioid mechanisms[36].

In summary, oyster mushrooms have shown potent antinociceptive and anti-inflammatory properties in several animal model studies and no side effects. However, further studies are needed to investigate the antinociceptive mechanisms in vivo, and human intervention studies of oyster mushrooms alone or in combination with conventional chemotherapy are also demanded to establish efficacy in humans.

Agaricus

Agaricus is the most common eubacterium among the whole macrofungi. The species number admitted by taxonomists is more than 200. It is a large family, which is named Psalliota Kummer in the early days, including Agaricus bisporus, Agaricus bitorquis, Agaricus blazei, Agaricus silvaticus, Agaricus macrospors and so on. We select three typical species (A. brasiliensis, A. bisporus var. hortensis and A. macrosporus) in order to elaborate the antinociceptive properties of Agaricus.

Agaricus rasiliensis and Agaricus bisporis var. hortensis

Fucogalactans from A. brasiliensis (EPF-Ab) and A. bisporus var. hortensis (EPF-Ah) have antinociceptive action, which is related to their structures. Fucogalactans play a positive role in antinociceptive, anti-inflammatory and anti-sepsis. Besides, they possess activities even after extraction[37]. The active ingredients are attained by their aqueous extraction and a series of purification. According to methylation analysis[38] and GC–MS, Komuraa et al.[37] concluded that EFP-Ab (Mw = 19.4 × 10[3 ]g/mol) had a (1 → 6)-linked α-D-Galp main-chain partially substituted in O-2 by non-reducing end-units of α-L-Fucp. EPF-Ah (Mw = 31.1 × 10[3 ]g/mol) had a similar main-chain with O-2 substitution, but was partially methylated at HO-3, as well as having 2.5% non-reducing end-units of β-D-Gal substitution (Figure 2). Analgesic activity was determined using the hot-plate method, acetic acid-induced writhing, formalin-induced pain in rats and many other classic methods[37,39]. There are different modes of action among different experiments. Above all, EFP-Ab and EFP-Ah prefer to cure inflammatory nociception and act at a central and peripheric level. These results showed that the structure determines the function; it is the (1 → 6)-linked α-D-galactopyranosyl main-chain that determines the analgesic property of A. brasiliensis and A. bisporus var. hortensis. Many articles have reported that a lot of other basidiomycetes' fruiting bodies or cultivated mycelium such as P. pulmonarius, Lentinus edodes, Coprinus comatus, and Hericium erinaceus, which have the main-chain, also can inhibit nociception[20,40,41,42].

Structure of the fucogalactans EPF-Ab and EPF-Ah, obtained respectively from A. brasiliensis (A) and A. bisporus var. hortensis (B).

Agaricus macrosporus

Agaricus macrosporus is another species which has obvious analgesic effect by inhibiting neurolysin. The active ingredient of A. macrosporus is agaricoglycerides, which is a new class of fungal secondary metabolites that constitute esters of chlorinated 4-hydroxy benzoic acid and glycerol[43]. They are produced in cultures of the edible mushroom, which is different from the two species described above. There are seven structures of agaricoglycerides in cultures according to reports, and agaricoglyceride A is the main active principle of the crude extract of A. macrosporus (Figure 3). Neurolysin inhibitors are likely to enhance the analgesic properties of neurotensin and/or dynorphin A by inhibiting cleavage and inactivation of these peptides[44,45]. The agaricoglyceride A just shows strong activities against neurolysin. Many studies suggested that the production of agaricoglycerides and related metabolites in culture is widespread in the genus Agaricus[46,47,48] and other genera and families, such as Triticum, Psathyrella, Hypholoma[49,50] and Stropharia, are able to synthesise these aromatic triglycerides.

Chemical structures of metabolites isolated from Agaricus macrosporus. 1: Agaricoglyceride A; 2: Agaricoglyceride B; 1a/b: Monoacetyl-agaricoglycerides A (isolated as inseparable mixture); 3: Agaricoglyceride C; 4: Agaricoglyceride D; 5: DCMB; 6: 3,5-Dichloro-4-anisic acid; 7: Agaricic ester.

The genus Agaricus generally has an analgesic effect in spite of the kinds of effective ingredients and the different modes of action.

Coriolus versicolor

Coriolus versicolor, also referred to as the turkey-tail mushroom, contains large quantities of β-glucans that act to stimulate the immune system. Coriolus can dramatically regenerate and rejuvenate the body. Its most active medicinal components are biological response modifiers called protein-bound polysaccharides. Both extracellular and intracellular polysaccharopeptides of C. versicolor are physiologically active as biological response modifiers. The best known commercial polysaccharopeptide preparations of C. versicolor are polysaccharopeptide Krestin (PSK) and polysaccharopeptide (PSP). What is more, PSP and PSK have been investigated for possessing anticancer, anti-inflammatory and antinociceptive activities and immunopotentiation[51,52,53,54,55].

The PSP from the mushroom C. versicolor has immunomodulatory and anti-tumour activities, which has been used as a drug for cancer patients[56,57]. Ng et al.[54] studied the analgesic activity of PSP in the hot-plate test upon intraperitoneal administration to ICR mice and found that its analgesic activity would add to its attribute as an immunomodulatory and anti-tumour drug. Pain response in mice was significantly suppressed after receiving an intraperitoneal injection of C. versicolor PSP. Then, it was demonstrated that C. versicolor PSP possesses analgesic activity, which is beneficial for cancer patients as an immunomodulatory and anti-tumour drug[54]. In addition to this, one study shows that the analgesia produced by PSP is mediated by IL-2, which is activated by PSP and interacts with IL-2 receptors in the mediobasal hypothalamus (MBH)[55]. Rats were divided at random into different groups to test and the degree of analgesic effect of PSP was evaluated by the pain threshold (mA) or by the percentage increase from baseline pain threshold. The experiment results demonstrated that the analgesia appeared only 1 h after PSP administration and began to decrease after another hour. The phenomenon suggested that PSP-produced analgesia might be mediated by some intermediary substances activated by PSP[55].

On the whole, C. versicolor as a medicinal mushroom is widely used to treat cancer and enhance the immune system. Its PSK and PSP are the main bioactive components possessing anti-tumour, antimicrobial, hepato-protective and analgesic effects. Even so, the clinical applications need further study.

Cordyceps

Among the whole macrofungi family, Cordyceps is a special genus of entomogenous fungi that forms a fruiting body mainly on pupae or larvae[58]. The most typical species is Cordyceps sinensis (CS, caterpillar fungus). It is named Dong-Chong-Xia-Cao in Chinese, which translates as winter worm and summer grass. CS has many pharmacological actions such as modulation of immune response, inhibition of tumour growth, induction of cell apoptosis, antinociception and so on[59,60,61,62]. The effective constituent of antinociception in CS is cordymin, a peptide purified from its culture and fruiting bodies. Some studies have shown that cordymin inhibits the acetic acid-induced abdominal constriction in mice in a dose-dependent manner, which shows that cordymin had a peripheral antinociceptive effect. In addition to the results of the hot-plate test which is used for the assessment of the central antinociceptive effect, cordymin significantly inhibited the reaction time to thermal stimuli[63,64]. In brief, cordymin has antinociceptive effect in both peripheral and central aspects. Cordymin-1, cordymin-2 and cordymin-4 inhibited neurolysin in a dose-dependent manner and neurolysin has been reported to have analgesic properties in animal models[65]. As a result, cordymin is a potent anti-inflammatory and analgesic medicine and CS is an effective analgesic.

Others

Not only the four genuses described above but also many others have the effect of analgesia. Lu et al.[66] concluded that the dry matter of culture broth (DMCB) of Termitomyces albuminosus in submerged culture, its crude saponin extract (CSE) and crude polysaccharide extract (CPE) inhibited the mouse ear swelling by 61.8%, 79.0% and 81.6%, respectively. Then the dates illustrated that T. albuminosus possessed the analgesic activity owing to saponins and polysaccharides, which are its major active constituents[66]. One study, designed by Young-Mi Park et al., demonstrated that the methanol extract from Inonotus obliquus had analgesic activity due to the inhibition of iNOS and COX-2 expression via the down-regulation of NF-κB binding activity[67]. In addition, Kim et al.[68] found that the EtOH extract of Phellinus linteus (PLE) could significantly reduce the numbers of writhing induced by acetic acid in mice. The results indicated that PLE had potent antinociceptive effect, which might be mediated by its anti-inflammatory action[68]. Moreover, Ruthes et al.[69] studied and found that Lactarius rufus had the anti-inflammatory and antinociceptive potential of their polysaccharides evaluated using the formalin model. Soluble β-D-glucan isolated from fruiting bodies of L. rufus produced potent inhibition of inflammatory pain caused by formalin when compared with the insoluble one[69]. Furthermore, a recent study stated that Grifola frondosa has important and antinociceptive effects in acetic acid-induced pain and formalin-induced inflammatory pain at the dose level of 500 mg/kg in mice[70]. Therefore, G. frondosa may be used as an alternative medicine for inflammatory pain.

Conclusion

Edible mushrooms have been widely used in some cultures as traditional medicines to treat diseases including diabetes and cancer, and to stimulate the immune system. Pain is intuitive for feelings of these diseases such as cancer, inflammation and injuries. As a result, the analgesic effects of edible fungi have a wide range of applications. The active components in many mushrooms with analgesic effects are very clear. In our review, edible mushrooms including P. pulmonarius, A. brasiliensis, A. bisporus var. hortensis, A. macrosporus, C. versicolor and CS have been investigated that possessed antinociceptive and anti-inflammatory effects owing to their bioactive components such as β-glucan, agaricoglyceride A, polysaccharopeptide and cordymin as well as other active components (Table 1). What is more, there are barely any side effects caused by toxicity of edible mushrooms in vitro and in vivo. However, further research is required with clinical trials and applications.

Table 1

Bioactive components/extracts from edible mushrooms with analgesic effect

Abbreviations list

CPE, crude polysaccharide extract; CS, Cordyceps sinensis; CSE, crude saponin extract; DMCB, dry matter of culture broth; HEE, hydroethanolic extract; MBH, mediobasal hypothalamus; PKC, protein kinase C; PMA, phorbol myristate acetate; PSK, polysaccharopeptide Krestin; PSP, polysaccharopeptide; TRP, transient receptor potential.

Acknowledgement

This work was supported by the Foundation of Ji'nan Science and Technology Development Program (201302055).

Authors contribution

All authors contributed to conception and design, manuscript preparation, read and approved the final manuscript.

Competing interests

None declared.

Conflict of interests

None declared.

A.M.E

All authors abide by the Association for Medical Ethics (AME) ethical rules of disclosure.

References

  • 1. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001 Sep;413(6852):203-10.
  • 2. Velazquez KT, Mohammad H, Sweitzer SM. Protein kinase C in pain: involvement of multiple isoforms. Pharmacol Res 2007 Jun;55(6):578-89.
  • 3. Scholz J, Woolf CJ. Can we conquer pain?. Nat Neurosci 2002 Nov;51062-7.
  • 4. Tominaga M . Nociception and TRP channels. Handb Exp Pharmacol 2007;179489-505.
  • 5. Caterina MJ, Julius D. Sense and specificity: a molecular identity for nociceptors. Curr Opin Neurobiol 1999 Oct;9(5):525-30.
  • 6. McCleskey EW, Gold MS. Ion channels of nociception. Annu Rev Physiol 1999;61835-56.
  • 7. Baron A, Deval E, Salinas M, Lingueglia E, Voilley N, Lazdunski M. Protein kinase C stimulates the acid-sensing ion channel ASIC2a via the PDZ domain-containing protein PICK1. J Biol Chem 2002 Dec;277(52):50463-8.
  • 8. Ferreira J, Triches KM, Medeiros R, Calixto JB. Mechanisms involved in the nociception produced by peripheral protein kinase c activation in mice. Pain 2005 Sep;117(1–2):171-81.
  • 9. Premkumar LS, Raisinghani M, Pingle SC, Long C, Pimentel F. Down-regulation of transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation. J Neurosci 2005 Dec;25(49):11322-9.
  • 10. Chang ST, Miles PG. Mushrooms: cultivation, nutritional value, medicinal effect, and environmental impact 19894-6.
  • 11. Miles P, Chang S-T. Mushroom biology Concise basics and current developments 1997.
  • 12. Breene WM . Nutritional and medicinal value of specialty mushrooms. J Food Protect 1990;53883.
  • 13. Johl PP, Sodhi HS, Dhanda S, Kapoor S. Mushrooms as medicine—a review. J Plant Sci Res 1995–6;11–1273.
  • 14. Obodai M, Vowotor KA. Performance of different strains of species under Ghanian conditions. J Food Technol Afr 2002;198-100.
  • 15. Tong HB, Xia FG, Feng K. Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of . Bioresour Technol 2009 Feb;100(4):1682-6.
  • 16. Garcha HS, Khann PK, Soni GL, . Nutritional importance of mushroom Mushroom biology and mushroom products 1993227-35.
  • 17. Chang ST . The development of the mushroom industry in China, with a note on possibilities for Africa. Acta Ed Fung 2005;123-19.
  • 18. Moreno-Rojas R, Díaz-Valverde MA, Arroyo BM, González TJ, Capote CJB. Mineral content of gurumelo (Amanita ponderosa). Food Chem 2004;85325-30.
  • 19. Manzi P, Gambelli L, Marconi S, Vivanti V, Pizzoferrato L. Nutrients in edible mushrooms: an inter-species comparative study. Food Chem 1999;65477-82.
  • 20. Smiderle FR, Olsen LM, Carbonero ER, Marcon R, Baggio CH, Freitas CS. A 3-O-methylated mannogalactan from : structure and antinociceptive effect. Phytochemistry 2008 Nov;69(15):2731-6.
  • 21. Smith JE, Sullivan R, Rowan N. The role of polysaccharides derived from medicinal mushrooms in cancer treatment programs: current perspectives (review). Int J Med Mushrooms 2003;5217-23.
  • 22. Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol 2007;184-19.
  • 23. Wasonga CG, Okoth SA, Mukuria JC, Omwandho CO. Mushroom polysaccharideextracts delay progression of carcinogenesis in mice. J Exp Ther Oncol 2008;7(2):147-52.
  • 24. Yatsuzuka R, Nakano Y, Jiang S, Ueda Y, Kishi Y, Suzuki Y. Effect of Usuhiratake ) on sneezing and nasal rubbing in BALB/c mice. Biol Pharm Bull 2007 Aug;30(8):1557-60.
  • 25. Mizuno T, Hagiwara T, Nakamura T, Ito H, Shimura K, Sumiya T. Antitumor activity and some properties of water-soluble polysaccharides from “Himematsutake,” from the fruiting body of . Agric Biol Chem 1990;542889-96.
  • 26. Toklu HZ, Sener G, Jahovic N, Uslu B, Arbak S, Yegen BÇ. β-Glucan protects against burn-induced oxidative organ damage in rats. Int Immunopharmacol 2006 Feb;6(2):156-69.
  • 27. Dore CMPG, Azevedo TCG, Souza MCR, Rego LA, Dantas JCM, Silva FRF. Anti-inflammatory, antioxidant and cytotoxic actions of β-glucan-rich extract from mushroom. Int Immunopharmacol 2007 Sep;7(9):1160-9.
  • 28. Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol 2007;184-19.
  • 29. Smiderle FR, Olsen LM, Carbonero ER, Baggio CH, Freitas CS, Marcon R. Anti-inflammatory and analgesic properties in a rodent model of a (1→3),(1→6)-linked β-glucan isolated from . Eur J Pharmacol 2008 Nov;597(1–3):86-91.
  • 30. Baggio CH, Freitas CS, Marcon R, de Paula, Wernera MF, Rae GA, Smiderle FR. Antinociception of β-d-glucan from is possibly related to protein kinase C inhibition. Int J Biol Macromol 2012 Apr;50(3):872-7.
  • 31. Baggio CH, Freitas CS, Martins DF, Mazzardo L, Smiderle FR, Sassaki GL. Antinociceptive effects of (1/3),(1/6)-linked β-glucan isolated from in models of acute and neuropathic pain in mice: evidence for a role for glutamatergic receptors and cytokine pathways. J Pain 2010 Oct;11(10):965-71.
  • 32. Roy SK, Das D, Mondal S, Maiti D, Bhunia B, Maiti TK. Structural studies of an immunoenhancing water-soluble glucan isolated from hot water extract of an edible mushroom, , cultivar Assam Florida. Carbohydr Res 2009 Dec;344(18):2596-601.
  • 33. Jose N, Ajith TA, Janardhanan KK. Methanol extract of the oyster mushroom, , inhibits inflammation and platelet aggregation. Phytother Res 2004 Jan;18(1):43-6.
  • 34. Ganeshpurkar A, Rai G. Experimental evaluation of analgesic and anti-inflammatory potential of Oyster mushroom . Indian J Pharmacol 2013 Jan–Feb;45(1):66-70.
  • 35. Suseem SR, Saral MA, Reddy NP, Gregory M. Evaluation of the analgesic activity of ethyl acetate, methanol and aqueous extracts of mushroom. Asian Pac J Trop Med 2011 Feb;4(2):117-20.
  • 36. Vasudewa NS, Abeytunga DT, Ratnasooriya WD. Antinociceptive activity of an edible mushroom in rats. Pharm Biol 2007;45533-40.
  • 37. Komuraa DL, Carbonerob ER, Grachera AHP, Baggio CH, Freitas CS, Marcon R. Structure of fucogalactans and their anti-inflammatory and antinociceptive properties. Bioresour Technol 2010 Aug;101(15):6192-9.
  • 38. Ciucanu I, Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 1984;131209-17.
  • 39. Ruthes AC, Rattmann YD, Malquevicz-Paiva SM, Carbonero ER, Córdova MM, Baggio CH. Array. Carbohydr Polym 2013 Jan;92(1):184-91.
  • 40. Carbonero ER, Gracher AHP, Komura DL, Marcon R, Freitasc CS. Array. Food Chem 2008 Dec;111(3):531-7.
  • 41. Fan J, Zhang J, Tang Q, Liu Y, Zhang A, Pan Y. Structural elucidation of a neutral fucogalactan from the mycelium of . Carbohydr Res 2006 Jul;341(9):1130-4.
  • 42. Zhang A, Zhang J, Tang Q, Jia W, Yang Y, Liu Y. Structural elucidation of a novel fucogalactan that contains 3-O-methyl rhamnose isolated from the fruiting bodies of the fungus, Hericium erinaceus. Carbohydr Res 2006 Apr;341(5):645-9.
  • 43. Stadler M, Hellwig V, Mayer-Bartschmid A, Denzer D, Wiese B, Burkhardt N. Novel analgesic triglycerides from cultures of and other basidiomycetes as selective inhibitors of neurolysin. J Antibiot 2005 Dec;58(12):775-86.
  • 44. Vincent B, Dive V, Yiotakis A, Smadja C, Maldonado R, Vincent JP. Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation and . Brit J Pharmacol 1995 Jul;115(6):1053-63.
  • 45. Jirácek J, Yiotakis A, Vincent B, Checler F, Dive V. Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a schematic approach based on combinatorial chemistry of phosphinic peptides. J Biol Chem 1996 Aug;271(32):19608-11.
  • 46. Hirotani M, Sai K, Nagai R, Hirotani S, Takayanagi H, Yoshikawa T. Blazeispirane and protoblazeispirane derivatives from the cultured mycelia of the fungus . Phytochemistry 2002 Nov;61(5):589-95.
  • 47. Hirotani M, Sai K, Hirotani S, Yoshikawa T. Blazeispirols B, C, E and F, des-A-ergostane-type compounds from the cultured mycelia of the fungus Agaricus blazei. Phytochemistry 2002 Mar;59(5):571-7.
  • 48. Zapf S, Anke T, Dasenbrock H, Steglich W. Antifungal metabolites from Agaricus sp. 89139. Bioengeneering ;192.
  • 49. Hautzel R, Anke H. Screening of ascomycetes and basidiomycetes for plant growth regulating substances: introduction of the gibberrellic acid induced de novo synthesis of hydrolytic enzymes in embryoless seeds of Triticum aestivum as test system. Z Naturforsch 1990;45C1093-8.
  • 50. Swarts HJ, Verhagen FJM, Field JA, Wijnberg JBPA. Trichlorinated phenols from . Phytochemistry 1998;49203-6.
  • 51. Cho HJ, Shim MJ, Choi EC, Kim BK. Studies of constituents of higher fungi of Korea LVII. Comparison of various antitumor constituents of . Kor J Mycol 1988;16162-74.
  • 52. Sakagami H, Aoki T, Simpson A, Tanuma SI. Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK (review). Anticancer Res 1991 Mar–Apr;11(2):993-1000.
  • 53. Li XY, Wang JF, Zhu PP, Liu L, Ge JB, Yang SX. Immune enhancement of a polysaccharides peptides isolated from . Acta Pharmacol Sinica 1990 Nov;11(6):542-5.
  • 54. Ngand TB, Chan WY. Polysaccharopeptide from the mushroom possesses analgesic activity but does not produce adverse effects on female reproductive or embryonic development in mice gen. Pharmacology 1997;29(2):269-73.
  • 55. Shan G, Hui-Qin Z, Wei-Ping Y, Qi-Zhang Y, Yi Z, Zhen-Lun G. Involvement of interleukin-2 in analgesia produced by polysaccharide peptides. Acta Pharmacologica Sinica 1998 Jan;19(1):67-70.
  • 56. Liao ML, Zhao JM, . Stage 11 clinical tests of PSP in the treatment of lung cancer Proceedings of international symposium on PSP 1993243-56.
  • 57. Shi JH, Chen T, Lian ZR, . Clinical research of the effect of PSP on the immunological function of stomach cancer patients during operation and chemotherapy Proceedings of international symposium on PSP 1993232-40.
  • 58. So-Young W, Eun-Hee P. Anti-inflammatory and related pharmacological activities of cultured mycelia and fruiting bodies of .
  • 59. Kuo YC, Tsai WJ, Wang JY, Chang SC, Lim CY, Shiao MS. Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from . Life Sci 2001 Jan;68(9):1067-82.
  • 60. Kuo YC, Lin CY, Tsai WJ, Wu CL, Chen CF, Shiao MS. Growth inhibitors against tumor cells in other than cordycepin and polysaccharides. Cancer Invest 1994;12(6):611-5.
  • 61. Bok JW, Lermer L, Chilton J, Klingeman HG, Towers GH. Antitumor sterols from the mycelia of . Phytochemistry 1999 Aug;51(7):891-8.
  • 62. Yang LY, Huang WJ, Hsieh HG, Lin CY. H1-A extracted from suppresses the proliferation of human mesangial cells and promotes apoptosis, probably by inhibiting the tyrosine phosphorylation of Bcl-2 and Bcl-XL. J Lab Clin Med 2003 Jan;141(1):74-83.
  • 63. Collier HO, Dinneen JC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 1968;32295-310.
  • 64. Qian GM, Pan GF, Guo JY. Anti-inflammatory and antinociceptive effects of cordymin, a peptide purified from the medicinal mushroom . Nat Prod Res 2012;26(24):2358-62.
  • 65. Tyler BM, Cusack B, Douglas CL, Souder T, Richelson E. Evidence for additional neurotensin receptor subtypes: neurotensin analogues that distinguish between neurotensin-mediated hypothermia and antinociception. Brain Res 1998 May;792(2):246-52.
  • 66. Lu YY, Ao ZH, Lu ZM, Xu HY, Zhang XM, Dou WF. Analgesic and anti-inflammatory effects of the dry matter of culture broth of and its extracts. J Ethnopharmacol 2008 Dec;120(3):432-6.
  • 67. Park YM, Won JH, Kim YH, Choi JW, Park HJ, Lee KT. In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of . J Ethnopharmacol 2005 Oct;101(1–3):120-8.
  • 68. Kim SH, Song YS, Kim SK, Kim BC, Lim CJ, Park EH. Anti-inflammatory and related pharmacological activities of the n-BuOH subfraction of mushroom . J Ethnopharmacol 2004 Jul;93(1):141-6.
  • 69. Ruthes AC, Carbonero ER, Córdova MM, Baggio CH, Santos ARS, Sassaki GL. Array. Carbohydr Polym 2013 Apr;94(1):129-36.
  • 70. Han C, Cui B. Pharmacological and pharmacokinetic studies with agaricoglycerides, extracted from , in animal models of pain and inflammation. Inflammation 2012 Aug;35(4):1269-75.
Licensee to OAPL (UK) 2013. Creative Commons Attribution License (CC-BY)

Bioactive components/extracts from edible mushrooms with analgesic effect

Edible mushrooms Bioactive components/extracts of analgesic effect References
Pleurotus pulmonarius β-Glucans [25-32]
Pleurotus florida Hydroethanolic extract [34]
Pleurotus eous Methanol and aqueous extracts [35]
Agaricus brasiliensis Fucogalactan (EPF-Ab) [37]
Agaricus bisporus var. hortensis Fucogalactan (EPF-Ah) [37]
Agaricus macrospores Agaricoglycerides [43-48]
Coriolus versicolor Polysaccharopeptides [51-57]
Cordyceps Cordymin [63-65]
Termitomyces albuminosus Crude saponin extract Crude polysaccharide extract [66]
Inonotus obliquus Methanol extract [67]
Phellinus linteus EtOH extract [68]
Lactarius rufus Soluble β-D-glucan [69]
Grifola frondosa Agaricoglycerides [70]